Characterization of LIMA1 and its emerging roles and potential therapeutic prospects in cancers

被引:4
|
作者
Wang, Xiaoxiao [1 ]
Zhang, Chao [1 ]
Song, Huangqin [1 ]
Yuan, Junlong [1 ]
Zhang, Xiaomin [1 ]
Yuan, Yiran [1 ]
Zhang, Lei [2 ,3 ]
He, Jiefeng [1 ,2 ]
机构
[1] Shanxi Med Univ, Shanxi Acad Med Sci, Shanxi Bethune Hosp, Tongji Shanxi Hosp,Hosp 3, Taiyuan, Peoples R China
[2] Shanxi Med Univ, Shanxi Bethune Hosp, Tongji Shanxi Hosp, Shanxi Acad Med Sci,Dept Hepatobiliary Surg,Hosp 3, Taiyuan, Peoples R China
[3] Huazhong Univ Sci & Technol, Tongji Hosp, Inst Hepatopancreato Biliary Surg, Tongji Med Coll,Hepat Surg Ctr, Wuhan, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
基金
中国国家自然科学基金;
关键词
actin cytoskeleton; LIMA1; cells migration and metastatic; EMT; angiogenesis; cancer progression; EPITHELIAL PROTEIN LOST; REGULATES ACTIN ORGANIZATION; NEOPLASM EPLIN; ENDOTHELIAL-CELLS; CROSS-LINKING; DYNAMICS; GROWTH; ALPHA; ADHESION; OSTEOSARCOMA;
D O I
10.3389/fonc.2023.1115943
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Actin is the most abundant and highly conserved cytoskeletal protein present in all eukaryotic cells. Remodeling of the actin cytoskeleton is controlled by a variety of actin-binding proteins that are extensively involved in biological processes such as cell motility and maintenance of cell shape. LIM domain and actin-binding protein 1 (LIMA1), as an important actin cytoskeletal regulator, was initially thought to be a tumor suppressor frequently downregulated in epithelial tumors. Importantly, the deficiency of LIMA1 may be responsible for dysregulated cytoskeletal dynamics, altered cell motility and disrupted cell-cell adhesion, which promote tumor proliferation, invasion and migration. As research progresses, the roles of LIMA1 extend from cytoskeletal dynamics and cell motility to cell division, gene regulation, apical extrusion, angiogenesis, cellular metabolism and lipid metabolism. However, the expression of LIMA1 in malignant tumors and its mechanism of action have not yet been elucidated, and many problems and challenges remain to be addressed. Therefore, this review systematically describes the structure and biological functions of LIMA1 and explores its expression and regulatory mechanism in malignant tumors, and further discusses its clinical value and therapeutic prospects.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Extracellular Matrix: Emerging Roles and Potential Therapeutic Targets for Breast Cancer
    Zhao, Yunchun
    Zheng, Xiaoling
    Zheng, Yongquan
    Chen, Yue
    Fei, Weidong
    Wang, Fengmei
    Zheng, Caihong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [32] Therapeutic potential of anti-SIRPβ1 antibodies and its mechanism of action in cancers
    Oduori, Okechi S.
    Tanaka, Daisuke
    Takai, Tomoko
    Ueda, Takashi
    Sakamoto, Mariko
    Kotani, Takenori
    Saito, Yasuyuki
    Matozaki, Takashi
    Murata, Yoji
    CANCER SCIENCE, 2024, 115 : 1678 - 1678
  • [33] Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications
    Wu, William K. K.
    Wang, Guangshun
    Coffelt, Seth B.
    Betancourt, Aline M.
    Lee, Chung W.
    Fan, Daiming
    Wu, Kaichun
    Yu, Jun
    Sung, Joseph J. Y.
    Cho, Chi H.
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (08) : 1741 - 1747
  • [34] Emerging roles of a pivotal lncRNA SBF2-AS1 in cancers
    Lu, Qian
    Lou, Jun
    Cai, Ruyun
    Han, Weidong
    Pan, Hongming
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [35] Emerging roles of a pivotal lncRNA SBF2-AS1 in cancers
    Qian Lu
    Jun Lou
    Ruyun Cai
    Weidong Han
    Hongming Pan
    Cancer Cell International, 21
  • [36] The roles of LncRNA CARMN in cancers: biomarker potential, therapeutic targeting, and immune response
    Huafeng Liu
    Xuewen Liu
    Yanjun Lu
    Discover Oncology, 15 (1)
  • [37] The chromosome 21 kinase DYRK1A: emerging roles in cancer biology and potential as a therapeutic target
    Rammohan, Malini
    Harris, Ethan
    Bhansali, Rahul S.
    Zhao, Emily
    Li, Loretta S.
    Crispino, John D.
    ONCOGENE, 2022, 41 (14) : 2003 - 2011
  • [38] The chromosome 21 kinase DYRK1A: emerging roles in cancer biology and potential as a therapeutic target
    Malini Rammohan
    Ethan Harris
    Rahul S. Bhansali
    Emily Zhao
    Loretta S. Li
    John D. Crispino
    Oncogene, 2022, 41 : 2003 - 2011
  • [39] Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma
    Wan-Ling Ho
    Wen-Ming Hsu
    Min-Chuan Huang
    Kenji Kadomatsu
    Akira Nakagawara
    Journal of Hematology & Oncology, 9
  • [40] Therapeutic potential of Curcuma oil and its terpenoids in gynecological cancers
    Zhang, Yuan
    Peng, Fu
    Yu, Chenghao
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 157